EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY-NC-ND 4.0

Protocol of a randomized trial of “pathways,” a hope intervention for people undergoing treatment for advanced lung cancer

Laurie E McLouth, Courtney Blair, Brent J Shelton, Jennifer S Cheavens, Vilma Bursac, Jessica L Burris, Amy H Peterman, Jessica McFarlin, Jerod L Stapleton, Lynn Andreae, Lauren Corum, Amy Cowley und 1 weitere

Contemporary Clinical Trials · 2026-11 · 170 · 108447

DOI: 10.1016/j.cct.2026.108447 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2026-11. Verfasst von Laurie E McLouth und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Behavioral Science, Center for Health, Engagement, and Transformation, University of Kentucky, 800 Rose St., Lexington, KY 40536, USA; …. Hauptthemen laut MEDLINE: Lung Neoplasms, Depression, Hope. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Center for Clinical and Translational Science, University of Kentucky, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Advanced cancer and its treatment can disrupt personal goal pursuits and attainment, which can imperil patient quality of life and increase risk for depression. Hope interventions foster the goal-pursuit skills exemplified by high-hope individuals and, based on a pilot trial, are a promising approach to support these patients. The current Phase II trial (NCT06047301) aims to determine the efficacy of a brief, hope intervention, "Pathways," in improving depression symptoms for people undergoing treatment advanced stage lung cancer with elevated distress. METHODS: In this two-arm randomized controlled trial, 234 people undergoing treatment for advanced stage lung cancer are randomized to Pathways or enhanced usual care. The Pathways intervention consists of a cancer resource guide and five sessions (150-180 min total) delivered primarily during infusion or by phone by nurse practitioners or social workers. Sessions focus on identifying values, setting goals, building pathways, and agency thinking. Enhanced usual care consists of receiving and reviewing the cancer resource guide with staff. Outcomes are assessed at baseline, mid-intervention, and at 2-, 6-, and 12-weeks post-intervention. The primary outcome is depression symptoms at 2 weeks. Secondary outcomes include measures of anxiety, demoralization, positive affect, meaning and peace, social and role function, and quality of life. RESULTS: Recruitment began in November 2023; 94 patients have enrolled as of November 5, 2025. CONCLUSION: If efficacious, Pathways may be a pragmatic point-of-care intervention to address cancer-related goal disruption and ultimately support the mental health and quality of life of patients receiving treatment for advanced lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsDepressionHopeHumansQuality of LifeRandomized Controlled Trials as TopicClinical Trials, Phase II as Topic

Stichwörter der Autor:innen

Advanced cancerDepressionHopeMental healthRandomized controlled trial

Autor:innen und Institutionen

  • Department of Behavioral Science, Center for Health, Engagement, and Transformation, University of Kentucky, 800 Rose St., Lexington, KY 40536, USA; Markey Cancer Center, University of Kentucky, 750 Rose St., Lexington,…
  • Markey Cancer Center, University of Kentucky, 750 Rose St., Lexington, KY 40536, USA. Electronic address: courtney.blair@uky.edu.
  • Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky, 2365 Harrodsburg Rd. #A289, Lexington, KY 40504, USA; Department of Psychology, University of Kentucky, 117 Funkhouser Dr., Lexi…
  • Department of Psychology, The Ohio State University, 1835 Neil Ave #225, Columbus, OH 43210, USA. Electronic address: cheavens.1@osu.edu.
  • Markey Cancer Center, University of Kentucky, 750 Rose St., Lexington, KY 40536, USA. Electronic address: vilma.bursac@uky.edu.
  • Markey Cancer Center, University of Kentucky, 750 Rose St., Lexington, KY 40536, USA; Department of Psychology, University of Kentucky, 117 Funkhouser Dr., Lexington, KY 40506, USA. Electronic address: jessica.burris@uk…

Förderung

  • Center for Clinical and Translational Science, University of Kentucky
  • National Cancer Institute

Zitieren

APA

McLouth, L. E., Blair, C., Shelton, B. J., Cheavens, J. S., Bursac, V., Burris, J. L., Peterman, A. H., McFarlin, J., Stapleton, J. L., Andreae, L., Corum, L., Cowley, A., & Arnold, S. M. (2026). Protocol of a randomized trial of “pathways,” a hope intervention for people undergoing treatment for advanced lung cancer. Contemporary Clinical Trials, 170, 108447. https://doi.org/10.1016/j.cct.2026.108447

Vancouver

McLouth LE, Blair C, Shelton BJ, Cheavens JS, Bursac V, Burris JL, et al. Protocol of a randomized trial of “pathways,” a hope intervention for people undergoing treatment for advanced lung cancer. Contemporary Clinical Trials. 2026;170:108447. doi:10.1016/j.cct.2026.108447

BibTeX
@article{McLouth2026,
  author = {McLouth, Laurie E and Blair, Courtney and Shelton, Brent J and Cheavens, Jennifer S and Bursac, Vilma and Burris, Jessica L and Peterman, Amy H and McFarlin, Jessica and Stapleton, Jerod L and Andreae, Lynn and Corum, Lauren and Cowley, Amy and Arnold, Susanne M},
  title = {Protocol of a randomized trial of “pathways,” a hope intervention for people undergoing treatment for advanced lung cancer},
  journal = {Contemporary Clinical Trials},
  year = {2026},
  volume = {170},
  pages = {108447},
  doi = {10.1016/j.cct.2026.108447}
}
Kostenlos starten →